Editor's Note A US analysis of state and county data shows a 23% drop in new COVID-19 cases, a 16% fall in patients hospitalized, and a 1.8% decline in deaths in the week ending February 14, compared with the previous week, the February 16 Reuters reports. Nationally, 5.7% of COVID-19…

Read More

Combatting COVID-19 is the top priority of President Joe Biden. On Day 1 of his presidency, he signed numerous executive orders, including one that aims to provide “a unified and effective response” to the crisis and one that mandates mask-wearing and social distancing on all federal properties. His strategy is…

Read More

Editor's Note Since emergency use authorization of the Pfizer-BioNTech and Moderna vaccines in December, the Centers for Disease Control and Prevention’s Vaccine Adverse Event Reporting System (VAERS) has received reports of allergic reactions including anaphylaxis. From December 14, 2020, through January 18, 2021, 9,943,247 doses of the Pfizer vaccine and…

Read More

Editor's Note In this study led by the University of Pennsylvania, Philadelphia, researchers find that during the early months of COVID-19, the personal and professional experiences of housestaff and faculty differed. Of 335 surgeons from five academic medical centers who completed a survey, 49.3% were housestaff and 50.7% were faculty.…

Read More

Editor's Note The Joint Commission, on February 8, issued a new Quick Safety addressing safe, equitable care during the COVID-19 pandemic. The Quick Safety focuses on actions organizations can take to: address racial and ethnic disparities remove barriers to providing safe, equitable healthcare. The pandemic has put a spotlight on…

Read More

Editor's Note This study led by researchers from NYU Grossman School of Medicine, Hassenfeld Children’s Hospital at NYU Langone, New York City, finds that children in the New York City metropolitan region at the epicenter of the COVID-19 outbreak had higher rates of perforated appendicitis compared with historical controls. Researchers…

Read More

Editor's Note The Food & Drug Administration, on February 9, issued an emergency use authorization (EUA) for Eli Lilly’s (Indianapolis, Indiana) combination therapy of two antibodies, bamlanivimab and etesevimab. The authorization is for the two antibodies to be administered together for treatment of mild to moderate COVID-19 in adults and…

Read More

Editor's Note This study by the Centers for Disease Control and Prevention (CDC) finds that during the COVID-19 pandemic, the prevalence of current depression, increased or newly initiated substance use, and suicidal thoughts/ideation has been higher for some racial and ethnic minority groups, especially Hispanics. A survey of 1,004 US…

Read More

Editor's Note This study led by researchers from Case Western Reserve University, Cleveland, Ohio, finds that patients with dementia are at a significantly higher increased risk for COVID-19, and the risk is higher still for Blacks with dementia. Analyzing electronic health records of 61.9 million adults in the US, the…

Read More

Editor's Note In a February 5 media briefing, the White House says it has invoked the Defense Production Act to help Pfizer produce more of its COVID-19 vaccine, and the same will hold true for Johnson & Johnson, should it receive Emergency Use Authorization for it’s vaccine, the February 5…

Read More